Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer
Clinical trial NCT02213042 · TERMINATED
Trial details
- NCT number
- NCT02213042
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-24
- Primary completion
- 2020-06-04
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.